Inflammatory Cytokines and the Risk of Cardiovascular Complications in Type 2 Diabetes

الملخص EN

This study evaluates peripheral blood T lymphocyte expression of inflammatory and proinflammatory cytokines as well as T regulatory (Treg) (FOXP3+CD25+CD4+) cells in type 2 diabetes (T2DM).

Participants included 40 T2DM and 30 healthy control subjects.

Twenty-four patients had no complications while 16 were afflicted with coronary heart disease (CHD).

Relative to healthy subjects, all T2DM patients showed a significant increase in expression of CD4+IFN-ϒ+, CD4+TNF-α+, and CD4+IL-8+ T cells (P<0.001) as well as CD4+IL-6+, CD4+IL-1β+, and IL-17+ T cells (P<0.05) while the ratios of Treg/Th1(CD4+IFN-ϒ+) and Treg/Th-17(CD4+IL-17+) cells were significantly decreased (P<0.05 and P<0.01).

T2DM patients with CHD showed a significant increase in CD4+IFN-ϒ+, CD4+TNF-α+, and CD4+IL-17+ T cells and a significant decrease in Treg/Th1 and Treg/IL-17 cells compared to T2DM patients without CHD (P<0.05).

In CHD-afflicted T2DM, HbA1c correlated positively with CD4+IFN-ϒ+ T cells (P<0.01), HDL correlated negatively with each of CD4+IL-8+ T cells and CD4+IL-17+ T cells (P<0.05), and LDL correlated positively with CD4+IL-1β+ T cells (P<0.05).

Conclusion.

This study shows that hyperglycemia and dyslipidemia correlate with increased inflammatory cytokine expression and suggests the involvement of T cells in the development of diabetes and its complications.